Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Jpn Circ J ; 63(2): 79-84, 1999 Feb.
Article in English | MEDLINE | ID: mdl-10084368

ABSTRACT

To evaluate the relationship between blood pressure control and the progression of brain atrophy in the elderly, patients with essential hypertension and brain atrophy were longitudinally evaluated using computerized tomography (CT). The study evaluated 48 patients with essential hypertension aged 46-78 years, and 30 sex- and age-matched normotensive control subjects. The extent of brain atrophy as determined by caudate head index (CHI), the inverse cella media index (iCMI), and Evans' ratio (ER) was estimated twice at an interval of 5-9 years (mean, 6.9 years). The mean annual increases in CHI (deltaCHI), iCMI (delta iCMI), and ER (deltaER) were evaluated. Mean blood volume in the common carotid artery (BF) and the decrease in BF per year (deltaBF) were also determined. The deltaCHI, delta iCMI, and deltaER increased with age in the hypertensive subjects as well as the control group across all age groups evaluated. The deltaCHI, delta iCMI, and deltaER were significantly greater in the patients with essential hypertension in their 50 s as compared with the controls. In patients with essential hypertension aged 65 years or older, the deltaCHI, delta iCMI, and deltaER were significantly lower in the group in whom the blood pressure was controlled within the range of borderline hypertension than the groups in which it was controlled in the range of normal or mild hypertension. In the younger patients under the age of 65 with essential hypertension, blood pressure control did not affect the deltaCHI, delta iCMI, and deltaER. The deltaCHI, delta iCMI, and deltaER were significantly correlated with deltaBF in both groups. These findings indicate that control of systolic blood pressure within the range of borderline hypertension may delay the progression of brain atrophy in elderly patients with essential hypertension.


Subject(s)
Antihypertensive Agents/therapeutic use , Brain/pathology , Dementia/prevention & control , Hypertension/complications , Aged , Alcoholism/complications , Atrophy , Blood Pressure , Blood Volume , Brain/diagnostic imaging , Carotid Artery, Common/physiopathology , Cerebrovascular Circulation , Cross-Sectional Studies , Dementia/etiology , Disease Progression , Female , Follow-Up Studies , Humans , Hyperlipidemias/complications , Hypertension/drug therapy , Male , Middle Aged , Sex Factors , Smoking/adverse effects , Tomography, X-Ray Computed
2.
Nihon Ronen Igakkai Zasshi ; 31(12): 961-8, 1994 Dec.
Article in Japanese | MEDLINE | ID: mdl-7699944

ABSTRACT

This longitudinal study was performed to clarify the relation between brain atrophy and common carotid hemodynamics. A total of 147 patients, including 70 males and 77 females, who had neither neurologic deficits nor organic lesions on computed tomography of the brain, were enrolled in this study. The ages of the patients ranged from 47 to 76 years (mean: 62 years) at the first diagnosis of brain atrophy. The patients were divided into three groups: 66 controls without hypertension or diabetes mellitus (Group I), 60 with hypertension (Group II) and 21 with both hypertension and diabetes mellitus (Group III). Brain atrophy was diagnosed by caudate head index (CHI). Mean blood flow volume (BF) at the right common carotid artery was measured by an ultrasonic quantitative flow measurement system. Both CHI and BF were measured twice at a mean interval 6.5 years. Increment in CHI per year (delta CHI) and decrement in mean blood flow volume per year (delta BF) were calculated. delta CHI of Group I and Group II had a significant relation with aging. delta CHI of Group III showed a larger increase than that of both Group I and Group II in subjects in the sixties. delta CHI had a significant relation with delta BF in each group. These results indicate that complication of both HT and DM, or decrement in mean blood flow volume may cause brain atrophy to progress.


Subject(s)
Brain/pathology , Carotid Arteries/physiopathology , Aged , Atrophy , Diabetes Complications , Female , Hemodynamics , Humans , Hypertension/complications , Longitudinal Studies , Male , Middle Aged
3.
No Shinkei Geka ; 20(5): 541-6, 1992 May.
Article in Japanese | MEDLINE | ID: mdl-1598129

ABSTRACT

The use of an ultrasonic transcranial Doppler arteriography (TCDA) technique for noninvasive diagnosis of cerebral aneurysm is described. Twenty one patients with intracranial aneurysm previously diagnosed by conventional angiography were evaluated with Trans-Scan (EME). Mapping image was used as a guide to identify parent artery and aneurysm. In four patients, we could not record aneurysmal blood flow because of their poor or non existent acoustic window. Good images were recorded in 17 patients. The location of aneurysms were A-com (1 case), Distal ACA (2 cases), IC (7 cases), MCA (3 cases), Basilar (1 case) and IC fusiform (3 cases). Two types of Doppler spectra were obtained from the aneurysmal blood flow. One was characterized by a high density zone along the base line and the other was characterized by a homogeneous high density zone. In both types, Doppler sound was characterized by low frequency sound. The low frequency sound reflects the turbulent flow in the aneurysm. The pattern of Doppler spectra obtained from ordinary arteries was characterized by a high density zone along the descending limb of the envelope. Doppler sound is characterized by high frequency sound. A homogeneous spectral pattern was obtained in both aneurysms and ordinary arteries. But it was possible to differentiate them by Doppler sound. Consequently to be able to hear Doppler sound is very important. We were able to detect fourteen of seventeen aneurysms (A-com 1/1, Distal ACA 1/2, IC 7/7, MCA 2/3, Basilar 1/1, and IC fusiform 2/3). The rate of detection was 82 percent. Aneurysm size ranged from 5mm x 4mm to 16mm x 18mm.(ABSTRACT TRUNCATED AT 250 WORDS)


Subject(s)
Cerebrovascular Circulation , Intracranial Aneurysm/physiopathology , Adult , Aged , Aged, 80 and over , Cerebral Angiography , Female , Hemodynamics , Humans , Intracranial Aneurysm/diagnostic imaging , Male , Middle Aged , Predictive Value of Tests , Ultrasonography
4.
Arzneimittelforschung ; 41(6): 588-91, 1991 Jun.
Article in English | MEDLINE | ID: mdl-1930345

ABSTRACT

The effects of 20 mg of orally administered isosorbide dinitrate (ISDN, Isocoronal R; CAS 87-33-2) on cerebral hemodynamics were investigated in 14 normal healthy volunteers (average age 32.6 years). The common carotid artery hemodynamics in the right supraclavicular region were measured using an ultrasonic quantitative flow measurement system. 2 h after drug administration, systolic blood pressure (15.5 mmHg, p less than 0.001) and mean blood pressure (7.2 mmHg, p less than 0.02) decreased significantly, but diastolic blood pressure did not change. A decrease in blood flow volume (2.85 ml/s, p less than 0.001) and blood flow velocity (7.00 cm/s, p less than 0.001), and an increase in mean vessel diameter (0.19 mm, p less than 0.05), and volume elasticity (0.68 x 10(5) dyn/cm2, p less than 0.02) were observed with ISDN. Mean vessel diameter increased gradually and reached its maximum at 4 h. However, the other maximal effects of ISDN were exerted at about 2 h. The ultrasonic quantitative flow measurement system was found to be useful in the case of repetitive measurements of the common carotid artery hemodynamics. It has been demonstrated that ISDN (20 mg/subject, p.o.) increases the diameter of the common carotid artery, although it decreases the blood flow in the common carotid artery.


Subject(s)
Carotid Arteries/drug effects , Hemodynamics/drug effects , Isosorbide Dinitrate/pharmacology , Adult , Blood Pressure/drug effects , Cerebrovascular Circulation , Humans , Middle Aged , Regional Blood Flow/drug effects , Vasodilation/drug effects
6.
Gan No Rinsho ; 31(11): 1367-71, 1985 Sep.
Article in Japanese | MEDLINE | ID: mdl-2999464

ABSTRACT

We evaluated whether assay of tissue polypeptide antigen (TPA) in the serum ia valuable for the determination of cancer stages compared to other tumor markers such as CEA, AFP, and ferritin. The study population consisted of 79 gastric cancer patients and 212 patients with benign gastroenteric disease. The percentage of positive cases for TPA (higher than 200u/l) was 41% in gastric cancer and 20% in active peptic ulcer. Serum TPA levels in well differentiated carcinoma and signet ring cell carcinoma were higher than that in other histological types. Serum TPA levels correlated well with the stage of the gastric cancer.


Subject(s)
Peptides/analysis , Stomach Neoplasms/immunology , Adenocarcinoma/immunology , Adenocarcinoma/pathology , Adenocarcinoma, Mucinous/immunology , Adenocarcinoma, Mucinous/pathology , Adenocarcinoma, Papillary/immunology , Adenocarcinoma, Papillary/pathology , Adult , Female , Humans , Intestinal Polyps/immunology , Male , Neoplasm Staging , Peptic Ulcer/immunology , Stomach Neoplasms/pathology , Tissue Polypeptide Antigen
7.
Gan No Rinsho ; 30(3): 265-71, 1984 Mar.
Article in Japanese | MEDLINE | ID: mdl-6201629

ABSTRACT

We evaluated whether assay of tissue polypeptide antigen (TPA) in sera is valuable for the determination of cancer stages compared to other tumor markers such as CEA, AFP, beta2-microglobulin, ferritin, and elastase-1. The study population consisted of cancer patients (33 gastric cancers, 7 colo-rectal cancers and 15 hepatomas), 169 patients with benign gastro-enteric diseases and 72 healthy volunteers. The percentage of positive cases for TPA (higher than 200 u/l) was 61% in gastric cancer, 71% in colo-rectal cancer and 87% in hepatoma. In certain non-cancerous conditions, such as gastric ulcer (active stage), acute hepatitis and chronic hepatitis, the TPA levels were increased over the level of healthy volunteers. There was no significant correlation between TPA and the other tumor markers. Our study suggests that TPA may be useful in the identification and evaluation of cancer patients.


Subject(s)
Carcinoma, Hepatocellular/immunology , Colonic Neoplasms/immunology , Liver Neoplasms/immunology , Peptides/analysis , Rectal Neoplasms/immunology , Stomach Neoplasms/immunology , Adolescent , Adult , Aged , Carcinoembryonic Antigen/analysis , Female , Ferritins/blood , Hepatitis/immunology , Humans , Liver Cirrhosis/immunology , Male , Middle Aged , Tissue Polypeptide Antigen , alpha-Fetoproteins/analysis
SELECTION OF CITATIONS
SEARCH DETAIL
...